210 related articles for article (PubMed ID: 21227392)
21. Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes.
Pietrusiński M; Kȩpczyński Ƚ; Jȩdrzejczyk A; Borkowska E; Traczyk-Borszyńska M; Constantinou M; Kaƚużewski B; Borowiec M
Cancer Biomark; 2017; 18(1):47-59. PubMed ID: 27814275
[TBL] [Abstract][Full Text] [Related]
22. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic markers of urothelial cancer based on DNA methylation analysis.
Chihara Y; Kanai Y; Fujimoto H; Sugano K; Kawashima K; Liang G; Jones PA; Fujimoto K; Kuniyasu H; Hirao Y
BMC Cancer; 2013 Jun; 13():275. PubMed ID: 23735005
[TBL] [Abstract][Full Text] [Related]
24. Methylation profiling of rectal cancer identifies novel markers of early-stage disease.
Leong KJ; Wei W; Tannahill LA; Caldwell GM; Jones CE; Morton DG; Matthews GM; Bach SP
Br J Surg; 2011 May; 98(5):724-34. PubMed ID: 21360524
[TBL] [Abstract][Full Text] [Related]
25. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
[TBL] [Abstract][Full Text] [Related]
26. [Characterisation of DNA methylation biomarkers for bladder cancer].
Antony P; Rose M; Gaisa NT; Alkaya S; Heidenreich A; Knüchel R; Dahl E
Pathologe; 2010 Oct; 31 Suppl 2():244-50. PubMed ID: 20798943
[TBL] [Abstract][Full Text] [Related]
27. Methylation status as a predictor of intravesical Bacillus Calmette-Guérin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor.
Husek P; Pacovsky J; Chmelarova M; Podhola M; Brodak M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):210-216. PubMed ID: 28344356
[TBL] [Abstract][Full Text] [Related]
28. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
29. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients.
Yegin Z; Gunes S; Buyukalpelli R
DNA Cell Biol; 2013 Jul; 32(7):386-92. PubMed ID: 23682613
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
[TBL] [Abstract][Full Text] [Related]
32. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
[TBL] [Abstract][Full Text] [Related]
33. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.
Tang H; Kan L; Ou T; Chen D; Dou X; Wu W; Ji X; Wang M; Zong Z; Mo H; Zhang X; Xiong D
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441304
[TBL] [Abstract][Full Text] [Related]
36. Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancer.
Serizawa RR; Ralfkiaer U; Dahl C; Lam GW; Hansen AB; Steven K; Horn T; Guldberg P
J Mol Diagn; 2010 Jul; 12(4):402-8. PubMed ID: 20413679
[TBL] [Abstract][Full Text] [Related]
37. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
Chung W; Bondaruk J; Jelinek J; Lotan Y; Liang S; Czerniak B; Issa JP
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1483-91. PubMed ID: 21586619
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
39. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
[TBL] [Abstract][Full Text] [Related]
40. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
